Navigation Links
Arthritis Foundation of India Trust named winner of 2009 IOF Linda Edwards Memorial Award
Date:9/23/2009

The International Osteoporosis Foundation (IOF) has awarded its prestigious 'IOF Linda Edwards Memorial Award' to the Arthritis Foundation of India Trust (AFI), one of 193 IOF member societies around the world. The award was presented today at the IOF Worldwide Osteoporosis Patient Society Conference, being held from September 22-25, 2009 in Beijing, China.

The award is named after the late Linda Edwards, a pioneer of osteoporosis advocacy who spearheaded the osteoporosis patient movement, both in the UK where she was director of the National Osteoporosis Society, and through her active role with the IOF. The unrestricted award (valued at 20,000 SFr) is presented to an IOF member society every two years. The award supports and recognizes the efforts of a relatively 'young' and growing society which has been carrying out exceptional and creative campaigns to increase awareness, prevention and knowledge of osteoporosis among the public and health professionals, while working to improve the care of patients at the national level.

Since its foundation in 2002 the AFI has grown into a strong organization which carries out numerous effective information campaigns and far reaching advocacy initiatives under the slogan "Bone Health a Right, Realize it". AFI Chairman Dr Sushil Sharma said, "In its endeavour to take information about osteoporosis and bone health to the common people, AFI is creating various communication programmes and we are hopeful that people will take full advantage of these programmes and ultimately attain our goal of total bone health." The work of the Foundation is outlined on its website http://www.arthfound.org.

Previous winners of the IOF Linda Edwards Memorial Award include patient societies from Greece (2007); Slovenia (2005); and Romania (2003).


'/>"/>

Contact: L. Misteli
news@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. Gene expression findings a step toward better classification and treatment of juvenile arthritis
2. New trigger for chronic inflammation in rheumatoid arthritis discovered
3. Researchers identify new risk factor gene for rheumatoid arthritis
4. Bad mix of bacterial remnants and genetics leads to arthritis
5. Inhibiting proteins may prevent cartilage breakdown in arthritis patients
6. Gene therapy demonstrates benefit in patients with rheumatoid arthritis
7. Anakinra for rheumatoid arthritis: A modest benefit with some risk
8. New therapeutic target identified for rheumatoid arthritis
9. Geisinger research: Antimalarial drug prevents diabetes in arthritis patients
10. New guidelines for treating rheumatoid arthritis
11. Stem cells offer cartilage repair hope for arthritis sufferers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/5/2015)... 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, reminds investors and media that ... is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series ... is themed Global Fraud: Where is the Trust in ...
(Date:4/20/2015)... 2015 Huntington Memorial Hospital is the first ... new miniaturized, wireless monitoring sensor to manage heart failure ... only FDA-approved heart failure monitoring device that has been ... physicians to manage heart failure. The CardioMEMS ... the pulmonary artery (PA) during a non-surgical procedure to ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... A research team led by U of T Mississauga scientists ... pair of cancer proteins, a finding that could ultimately lead ... effects. Working with scientists at the University of Central ... the Department of Chemical and Physical Sciences has created several ...
... has shown that the oldest complex life forms -- ... ago likely fed by osmosis. The researchers ... rangeomorphs and the air mattress-shaped erniettomorphs. These macroscopic organisms, ... outer membrane, much like modern microscopic bacteria, according to ...
... Researchers at the University of Oklahoma Health Sciences Center ... gene and high blood pressure. The results, which appear this ... on how we age and how we might live longer. ... factor for stroke, heart attack, heart failure, arterial aneurysm and ...
Cached Biology News:Disrupting a destructive duo: U of T Mississauga researchers inhibit cancer proteins 2Geobiologists propose that the earliest complex organisms fed by absorbing ocean buffet 2Geobiologists propose that the earliest complex organisms fed by absorbing ocean buffet 3Anti-aging gene linked to high blood pressure 2
(Date:6/1/2015)... Research and Markets ... of the "Oxidative Stress Assay Market ... (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-based), Technology ... Global Forecast to 2020" report to ... , The global oxidative stress ...
(Date:6/1/2015)... 2015 GenomeDx Biosciences today announced ... successfully classified various subtypes of bladder cancer ... biomarkers, including one type associated with resistance ... signature has potential as a tool to ... patients with muscle-invasive bladder cancers (MIBC). The ...
(Date:6/1/2015)... 2015  Novartis is highlighting data from an ... investigational chimeric antigen receptor (CAR) T cell therapy, ... specific types of hard-to-treat non-Hodgkin lymphoma. Findings from ... Pennsylvania,s Perelman School of Medicine (Penn) in adults ... lymphoma (DLBCL) and follicular lymphoma (FL) found an ...
(Date:6/1/2015)... IL (PRWEB) June 01, 2015 ... developing and manufacturing of chiral stationary phases (CSPs) ... options for its current and presenting solutions for ... to its portfolio. This valuable addition to its ... and effective advantage that can tackle projects for ...
Breaking Biology Technology:Oxidative Stress Assay Market 2015 - Global Forecast to 2020 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6Regis Technologies Offers Chiral Chromatography Service 2Regis Technologies Offers Chiral Chromatography Service 3
... N.J., July 18, 2011 Insmed Incorporated ... Andrea ("Andi") Holtzman Drucker, J.D. has been appointed to ... Counsel and Corporate Secretary, effective as of July 18, ... Whitten, President and Chief Executive Officer of Insmed, will ...
... Today the Alzheimer,s Association® in conjunction with ... Global Perspective" panel discussion during the Alzheimer,s Association ... leaders in the Alzheimer,s field and revealed new ... findings explored the impact of Alzheimer,s disease on ...
... SAN DIEGO, July 15, 2011 Biocept, Inc. announced ... Senior Vice President, Finance and Chief Financial Officer.  As ... the company,s accounting, finance, treasury, investor relations, risk management ... years of leadership experience in helping to build life ...
Cached Biology Technology:Andrea Drucker Joins Insmed as General Counsel 2Andrea Drucker Joins Insmed as General Counsel 3Women at the Center of the Global Alzheimer's Epidemic 2Women at the Center of the Global Alzheimer's Epidemic 3Women at the Center of the Global Alzheimer's Epidemic 4Biocept, Inc. Announces New CFO 2Biocept, Inc. Announces New CFO 3
... XS uniquely combines a single-channel sample processing ... 8-channel bulk reagent dispenser all in one ... using disposable pipette tips, the Precision XS ... dispenser is available for transferring larger volumes. ...
... ATP-Gamma-S binds to ATP-binding proteins. To ... FL fluorophore was linked through the ... its potential use for binding studies ... an important new substrate for Fhit ...
... of discovery races ever faster, you need a ... track. So our constant focus is on providing ... Thats why our Biomek 3000 Laboratory Automation Workstation ... as it is flexible. By integrating all aspects ...
... standard microarray image analysis software because of ... tools, visualizations, automation capabilities, performance and ease ... every GenePix scanner, and it also imports ... types of arrays. A wide range of ...
Biology Products: